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Abstract: In a blood-lipid liquid phantom the prototype near-infrared 
spectroscopy oximeter OxyPrem was calibrated against the INVOS® 5100c 
adult sensor in respect to values of regional tissue oxygen haemoglobin 
saturation (rStO2) for possible inclusion in the randomised clinical trial - 
SafeBoosC. In addition different commercial NIRS oximeters were 
compared on changing haemoglobin oxygen saturation and compared 
against co-oximetry. The best calibration was achieved with a simple offset 
and a linear scaling of the OxyPrem rStO2 values. The INVOS adult and 
pediatric sensor gave systematically different values, while the difference 
between the NIRO® 300 and the two INVOS sensors were magnitude 
dependent. The co-oximetry proved unreliable on such low haemoglobin 
and high Intralipid levels. 
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1. Introduction 
Near infrared spectroscopy (NIRS) enables non-invasive measurement of the regional tissue 
oxygen haemoglobin saturation (rStO2). rStO2 is correlated to both arterial (SaO2) and venous 
oxygen haemoglobin saturation (SvO2) [1] and is an estimate of the local oxygen balance, i.e. 
the oxygen delivery - oxygen consumption difference. The randomised clinical trial (RCT) 
SafeBoosC (Safeguarding the Brains Of Our Smallest Children) hypothesises that cerebral 
NIRS oximetry monitoring during the first three days of life of the extremely preterm infants 
can improve outcome [2]. The normal range of rStO2 in preterm infants is 55-85% as 
determined by the commercial device INVOS® 5100c using the adult sensor [3]. 
As a part of the SafeBoosC project, a prototype NIRS device ‘OxyPrem’ dedicated to the 
preterm infant head has been developed with the aim of combining reusable sensor technology 
with higher precision [2]. 
Validation of NIRS oximetry is difficult, as no reference standard exists. In-vivo it is 
usually validated by comparison of rStO2 with a weighted mean of SaO2 and SvO2 [4–10]. 
This method has limitations as it includes the imprecision of NIRS re-siting, the errors of 
measurement on SaO2 and SvO2, as well as extra-cerebral contribution to jugular venous 
blood. Furthermore, the arterial to venous volume ratios may be changing dependent on the 
level of oxygenation. In-vitro testing on solid state or liquid phantoms has the advantage of 
controllable optical properties and less variation [11,12]. 
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The present study had three objectives: 1) to calibrate the prototype OxyPrem against the 
INVOS® 5100c adult sensor for possible inclusion in the SafeBoosC trial; 2) to compare 
different commercial NIRS oximeters on changing haemoglobin oxygen saturation on a 
blood-lipid liquid phantom; 3) to compare the oximeters against co-oximetry. 
2. Methods 
2.1 Phantom 
The blood-lipid phantom consisted of a mixture of isotonic saline, erythrocyte suspension and 
Intralipid® 200 mg/ml. The erythrocyte suspension is made from human blood drawn into a 
citrate phosphate dextrose solutution that is centrifuged. The erythrocytes are finally 
suspended in a saline, adenine, glucose, and mannitol solution (SAG-M) to a hematocrit of 
about 64%. The mixture was 0.5% (5 mg fat/ml) Intralipid and a haematocrit of 1.5. It was 
contained in a five-litre bucket with a diameter of 17.5 cm. The NIRS sensors were equally 
distributed along the wall (Fig. 1) ensuring a distance of at least 8 cm from light sources and 
light detectors of different devices. The bucket was covered with a plastic film. The reduced 
scattering coefficient µs’ of 0.5% Intralipid® is about 0.5 mm−1 [13–16]. This is similar to 
scattering properties of the neonatal head [17,18]. Estimates of cerebral blood volume (CBV) 
in neonates vary considerably between studies ranging from 1.7 to 3.7 ml/100 g in primarily 
preterm populations [19–25], this corresponds to a ‘tissue haematocrit’ about 1.0 - 1.5% if 
blood haematocrit is 45% [26] and the specific gravity of brain tissue is 1.05 g/ml. 
The solution was pumped through an extracorporeal membrane oxygenator (STÖKERT 
SIII) with a servo-controlled heater maintaining a temperature of 37.5 °C. The flow on the 
pump was 1 litre per minute, and the fluid in the bucket was additionally circulated by a 
magnet stirrer (KEBO-Lab MR 2000). The gas flow to the membrane oxygenator consisted of 
a variable mixture of oxygen, nitrogen, and CO2 (Fig. 2). pH was kept about 7.4 by titration of 
sodium bicarbonate 1 mmol/ml. 
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 Fig. 1. The blood-lipid phantom seen from above before the fluid level was increased to well 
above the sensor level. The sensors are from the top and clock-wise: OxyPrem 1, OxyPrem 2, 
INVOS adult, NIRO, and INVOS pediatric. Only OxyPrem 2 was used for data collection. The 
tubings to and from the oxygenator were placed on both sides of the OxyPrem 1. 
 
Fig. 2. A schematic presentation of the phantom setup. White tubes contain blood. Gray tubes 
contain gas. The NIRS sensors and the heat exchanger are not presented in the diagram. 
O2 N2
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2.2 NIRS devices 
INVOS® 5100c uses one LED light source with wavelengths 730 and 810 nm and two light 
detectors, three and four centimeters from the source, respectively. This geometry is identical 
for the adult, the pediatric, and the neonatal sensor. 
NIRO 300 employs spatially resolved spectroscopy with lasers with wavelengths of 775, 
810, 847, and 919 nm. The light absorption coefficient is estimated by the decrease in 
reflected light as a function of distance from light source. By assuming a semi-infinite 
medium, knowing the wavelength dependence of the reduced scattering coefficient, then the 
spectral shape of the absorption coefficient can be calculated and the rStO2 estimated. In 
contrast to the INVOS, this algorithm was published [12,27]. Two light detectors are placed 
respectively 3.6 and 4.4 cm from the source. 
OxyPrem is designed and manufactured by the Biomedical Optics Research Laboratory 
(BORL) of the Division of Neonatology at the University Hospital Zurich, Switzerland. It 
applies four light sources with three light emitting diodes with nominal wavelengths of 760 
nm, 805 nm, and 870 nm, and two detectors. The pair-wise source-detector separation is 1.5 
and 2.5 cm. It employs a self-calibrating principle [28] using multiple light paths, which has 
proven to be advantageous [29]. 
In present study the INVOS adult sensor (SAFB-SM), the INVOS pediatric sensor 
(SPFB), the NIRO 300 sensor with detector at 3.6 and 4.4 cm from the source, and the 
OxyPrem sensor were used (Fig. 1). 
2.3 Blood sampling 
Blood for reference SO2 was drawn from the circuit before the oxygenator and analysed on an 
ABL-800® by co-oximetry. Part of each blood sample was immediately analysed for pH, pO2 
and pCO2, while the remains were spun. The precipitate containing the erythrocytes was then 
analysed for SO2. Differences in partial pressures of the two analyses served as quality 
control. This method was developed, as the ABL-800 cannot measure SO2 in a solution with 
an extremely low haemoglobin concentration and extremely high turbidity due to Intralipid. 
2.4 Experimental procedure 
Initially the phantom was oxygenated by flow of pure oxygen through the membrane 
oxygenator. This ensured theoretical baseline haemoglobin saturation very close to 100%. 
Next the oxygen was turned off and replaced by pure nitrogen flow to the oxygenator. This 
should lower the phantom oxygen content depending on the oxygen consumption of the blood 
and the oxygen contamination from outside the circuit. Lastly gas flow to the oxygenator was 
shifted back to pure oxygen, while the blood pump was stopped intermittently. 
2.5 Statistical analysis 
The blood sample pO2-SO2 pairs were fitted to the Hill’s equation [30] by the Nelder-Mead 
simplex algorithm with an initial estimate of coefficients of K = 1 and α = 1. Pre-spin SO2 
were calculated from the derived dissociation curve. Pairwise device comparisons with simple 
linear regression and all instruments were compared with the reference blood samples. All 
data handling was done in Matlab R2012b (Mathworks, Inc, Mass., USA). 
2.6 Calibration of OxyPrem 
For the SafeBoosC trial it is beneficial to have as little variability as possible caused by 
different measurement characteristics of different NIRS devices. Therefore we used the 
present experiment to determine a transformation of rStO2 values to make OxyPrem measure 
as similarly to the INVOS 5100c Adult SomaSensor as possible. 
If it is assumed that the present phantom constitutes a homogenous, semi-infinite medium 
differences between devices could derive from different basic assumptions of water content 
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and scattering properties [31]. It is not publically known what is assumed in the INVOS 
algorithm. 
The ‘pre-calibration' SO2 values are based on the assumptions of 0% water and µs’ of 0.5% 
Intralipid® while using absorption coefficients measured by Matcher et al. [27] and weighted 
with known LED spectra. 
In order to achieve OxyPrem SO2 values comparable to the INVOS Adult SomaSensor the 
assumptions of water content and scattering properties were systematically varied. For this, 21 
values from different saturations distributed approximately equally throughout the 16-94% 
range of the INVOS® adult sensor were chosen. Then a residual R was calculated as a 
squared sum of differences for several criteria m: OxyPrem SO2 - INVOS values, tHb - actual 
haemoglobin content and deviation from linear wavelength dependence of µs’. 
 
21 3
2
criterion m
1 1
( criterion [ ])
i m
m
i m
R w i
= =
= =
= Δ   (1) 
Then R was minimized in a bounded minimum search using the 'Nelder-Mead simplex direct 
search' algorithm with μs' for 760 nm, 805 nm, and 870 nm (all between 2 and 30 cm−1) and 
percentage of water (between 0 and 120%) as variables. Weighting factors wcriterion of the 
different criteria in the sum were each varied over several magnitudes to cover the range of 
one criterion only to all criteria having equal weights in the residual function. The result was 
in all cases either very unrealistic values for μs' with multiple variables in the bounds or 
resulting fits much worse compared to a simple linear scaling (Fig. 3). 
3. Results 
The calibration of the OxyPrem SO2 using a simple linear scaling (y = 1.47x – 33.1) resulted 
in a good fit (R-Squared 0.97; p<0.0001) (Fig. 3). 
 
Fig. 3. Linear regression on INVOS adult SomaSensor vs. the transformed OxyPrem SO2. 
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All three commercial device/sensor combinations gave systematically different values of 
SO2 (Fig. 4). The INVOS sensors showed limits of 15% and 95%. 
 
Fig. 4. Time-series of SO2 for each of the commercial NIRS devices and the blood samples. 
Important aspects: SO2 values differ in the low range between NIRO and INVOS; INVOS adult 
sensor has lower values than the neonatal sensor; and INVOS is clipping the values at 15% and 
95%. 
The INVOS adult and pediatric SomaSensors were also linearly correlated with the 
pediatric sensor reading systematically higher than the adult sensor (y = 0.96x + 17.91; R-
square 0.99). The INVOS adult SomaSensor was also linearly correlated with the NIRO, but 
with a different slope (y = 0.53x + 30.45; R-square 0.98) (Fig. 5). 
 
Fig. 5. Linear regression on INVOS adult SomaSensor vs. INVOS Pediatric SomaSensor 
(upper plot) and NIRO 300 (lower plot) SO2, respectively. 
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The co-oximetry SO22 was higher than any of the NIRS derived SO2 values (Fig. 4). pO2 
in the blood samples decreased during spinning when the pO2 was low before spinning, while 
at higher pre-spinning pO2 the oxygen tension increased (Table 1). 
Table 1. Co-oximetry Pre- and Post-spinning pO2 and SO2 
Post-spin  
pO2 (kPa) 
Pre-spin  
pO2 (kPa) 
Difference  
pO2 (kPa) 
Post-spin  
SO2 (%) 
Estim. pre-spin  
SO2 (%)* 
10.4 8.5 2.0 99 95 
3.1 3.4 -0.3 60 65 
2.2 2.4 -0.2 38 45 
1.8 2.1 -0.2 32 39 
5.0 5.3 -0.3 84 86 
6.9 7.0 -0.1 93 93 
14.9 7.5 7.4 97 92 
23.2 19.2 4.0 100 100 
*Estimated from the dissocation curve from the post-spin pO2 – SO2 data. 
4. Discussion 
It was possible to do a simple linear calibration of the prototype oxymeter to the commercial 
reference in a lipid phantom of 0.5% Intralipid, a haematocrit of 1.5%, and haemoglobin- 
oxygen saturation SO2 ranging from 30% to 100%. The INVOS 5100c Adult SomaSensor, the 
Pediatric SomaSensor, and the NIRO 300 gave systematically different values of SO2. The 
pair-wise relations between the commercial NIRS devices were, however, also all linear. 
The strength of the approach is that an estimate of the difference in absolute values are 
achieved on a maximum of oxygenation range, without the variation induced by different 
patients, sensor positions, and possibly depth of measurement. Moreover the co-oximetry is a 
potential reference standard not possible in in vivo measurements. The present phantom had 
optical properties simulating the neonatal head, but in future studies the effect of different 
scattering can be examined by changing the concentration of Intralipid. 
It is a weakness that we do not now exactly how the sensors behaved when immersed in 
the flowing fluid. The sensors were fixated, but some movement cannot be excluded. 
However the impact of a slightly curving sensor on the rStO2 has been shown to be minor 
[32]. Furthermore, the design relies on homogeneous oxygenation in the bucket. The in- and 
outlet from the bucket could theoretically induce heterogeneity. However moving a sensor 
around the rim of the bucket during mid-range steady state oxygenation gave no apparent 
indication of inhomogeneity. Another aspect is the violation of the semi-infinite geometry that 
is assumed in reflectance spectroscopy. In the present phantom the light boundaries are in 
essence the black rubber surrounding the detectors by more than 1 cm in the commercial 
devices. This material absorbs light and in that conforms to a semi-infinite boundary 
condition. Beyond that the light will hit the curved plastic surface of the bucket. It has been 
shown that the curvature has no effect, when the sensors are placed perpendicular to the 
curvature [33]. Although some will be reflected, this situation is not different from normal 
clinical use in newborns, where a bandage may be used to fix the sensor. Furthermore, it is 
unlikely that it will impact the rStO2 estimates substantially, as the impact on light intensities 
at the two detectors are likely to be proportionate thus potential wavelength dependent factors 
levels out. At last regarding the calibration for use in neonates the lack of haemoglobin F in 
the phantom should be noted. The differences between the optical spectra of haemoglobin F 
and haemoglobin A in the near infrared range are, however, modest and that the impact on the 
rStO2 is minor [34]. 
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It would have been preferable to make direct measurements of µs’ on the phantom. 
However, a recent study by Di Ninni found that that the optical properties of different samples 
from the same batch are almost identical, inter-batch variations are small, and the optical 
properties remains stable over time [13].This implies that the optical characteristics deduced 
from previous studies are likely to be close to the actual properties. 
The validation procedure, i.e. comparing the NIRS values with co-oximetry gave several 
problems. It was not possible to use the co-oximeter directly on samples from the phantom. 
The procedure of spinning the samples after a direct pO2 measurement introduced possible 
oxygen contamination of the sample. The repeatability of the co-oximetry measurements were 
good at saturations above 95%, but due to the shape of the oxygen-hemoglobin dissocation 
curve it is evident that oxygen contamination impacts the saturation most at the steep part of 
the curve around a saturation of 50%. The fact the blood sample analysis took more than fives 
minutes and that the phantom could not be held steady at midrange saturations made 
quantification of repeatability of the co-oximetry impossible. When the directly measured pO2 
was low there was a small decrease in pO2 during spinning while pO2 increased when the pre-
spin pO2 was higher. Simple diffusion of oxygen through the plastic tube would result in the 
opposite effect. Therefore it must be due to a left shift of the dissociation curve during 
centrifugation, but neither systematic changes in pH nor pCO2 were evident. That spinning in 
itself changes the dissociation curve is unlikely. As intracellular pH are well buffered [35] and 
changes in erythrocyte volume and/or shape are immediately reversed post-spinning [36] we 
are left with no evident explanation of our findings. Myers et al. by-passed these problems by 
creating a dual-layer phantom separating scattering and absorption into two layers [37]. This 
approach has not been validated. It violates the assumption of tissue homogeneity and 
possible inter-layer light piping could be an issue. In a similar blood-lipid phantom study 
validating the NIRO 300 (Hamamatsu Photonics, Hamamatsu City, Japan) the co-oximeter 
values seem less noisy than in present study, unfortunately the blood sampling procedures are 
not described in detail [12]. The difficulties with the reference blood co-oximetry prevent final 
conclusions on the NIRS device – co-oximetry validation. 
The present study is to our knowledge the first to compare commercial NIRS devices in a 
phantom. Interestingly NIRO 300 and INVOS 5100 adult sensor showed linearly correlated 
values with a large offset of 30.45% and a slope of 0.53, only. This means that the point of 
equality is 65%, i.e. approximately the normal cerebral oxygenation in adults. Many of the 
previous clinical studies comparing devices have the drawback of rather narrow oxygenation 
range. For instance the NIRO 300 and INVOS 4100/5100 adult sensor have been compared 
several times showing comparable mean values during steady state, but all studies had very 
few if any rStO2 values below 50% [38–41]. Regarding the difference between the INVOS 
adult and pediatric sensors, Dullenkopf et al. found a similar mean difference of 11.3 ± 5.37% 
(SD) between the two sensors, while Pocivalnik found a mean difference of 10% between the 
NIRO 300 and the INVOS neonatal sensor [42], that has been shown to give similar values to 
the paediatric sensor [43]. It is thus certain that despite same sensor geometry and LED 
wavelengths, the INVOS adult sensor gives systematically lower values than the comparable 
neonatal and paediatric sensors. The neonatal head has a higher water content than the adult 
head [31] and lower scattering due to less advanced myelination. 
It is interesting that all the pair-wise comparisons showed simple linear relations, while the 
algorithms behind OxyPrem, NIRO and INVOS are different [12,28,44,45]. The OxyPrem 
and NIRO calculate the difference in attenuation per distance between the two detectors. 
INVOS subtracts the attenuation at the near detector scaled by a factor that is proportional to 
the assumed superficial layer thickness from the attenuation at the far detector in order to 
archieve a signal only from deeper tissue. OxyPrem and NIRO assume wavelength dependent 
scattering, while this is probably not the case for INVOS. Apparently none of the algorithms 
account for the tissue water content. Lastly there is the possibility that it simply is a matter of 
different calibrations. Changing the assumption of superficial layer thickness will change the 
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INVOS rStO2 values by an offset and a scaling factor, it is therefore not unlikely that the 
difference between the INVOS sensors is a matter of different calibrations: “ … appropriate 
scale factors may be determined … for any desired specific application of the methodology 
disclosed herein, and used to calibrate or correlate the actual output of the implemented 
apparatus, for example by conventional computer data-processing techniques such as 
embodying the scale factors in appropriate look-up tables, for example” [45]. 
A limitation, when comparing or calibrating NIRS devices in a simple phantom, is that the 
sensor geometry in relation to the multi-layered structure of the human tissue - on the head: 
skin, scalp, and skull - are not emulated. In that respect it is important to emphasise that the 
shorter light source-detector distance of the OxyPrem compared to the INVOS could induce 
differences depending on the tissue interrogated. Future validation of the calibration should 
include measurements on neonates of different sizes and perhaps also adult heads to examine 
the generalizability of the calibration. How the differences between the commercial devices 
identified here will compare to in-vivo use remains to be tested, but it seems unlikely that 
NIRO 300 and INVOS adult sensor with similar geometry will be in good agreement when 
the cerebral oxygenation is either very low or very high despite the differences in algorithms 
Gagnon et al. did find a oxygenation dependent difference between INVOS and NIRO 300 in 
pigs on cardiopulmonary bypass and induced circulatory arrest [46]. Interestingly we 
previously found no difference in 'dynamic range' between the same two devices in the adult 
human forearm using arterial occlusion to achieve a wide range of StO2 values [47]. 
Clinical use in adults during surgery has removed the issue of poor reproducibility by 
using pre-surgery SO2 values as baseline. Our results suggest that treatment guideline stating 
that interventions should be initiated at a 20 percentage points drop in saturation [48] it should 
also state on what NIRS device. The trial by Murkin et al. on coronary bypass surgery showed 
reduced perioperative major organ morbidity and mortality and shorter postoperative hospital 
stay with INVOS monitoring. If conducted with the NIRO, it is likely to have resulted in 
fewer interventions, but at more severe desaturations [49]. 
In conclusion, it was possible to achieve good agreement between a prototype oximeter 
and a commercial oximeter by simple linear regression over a wide haemoglobin-oxygen 
saturation range. This is remarkable since the prototype oximeter uses a theory-based 
algorithm and the commercial instrument uses a proprietary algorithm or look-up table. Two 
other commercial systems also differed both in the similar simple way. 
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